Europe
Topical Drug Delivery Market, By Product Type {Topical (Solid, Liquid,
Semi-Solid), Transdermal (Patches, Gels)}, End-User (Hospitals, Clinics, Home
Healthcare, Diagnostic Centers), Distribution Channel (Direct Tenders, Retail),
Country (Germany, France, U.K., Belgium, Switzerland, Italy, Spain, Russia,
Turkey, Netherlands and Rest of Europe) – Trends and Forecast to 2024
Europe
Topical Drug Delivery Market is expected to reach USD 60.3 billion by 2024
from USD 31.3 billion in 2016, growing at a CAGR of 8.5% in the forecast period
2017 to 2024. The new market report contains data for historic years 2014 &
2015, the base year of calculation is 2016 and the forecast period is 2017 to
2024.
Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=europe-topical-drug-delivery-market-trends-forecast24
Some of the major companies operating in this market are:
· MedPharm
· Janssen Pharmaceuticals, Inc.,(Johnson & Johnson Services Inc.)
· Crescita TherapeuticsiNC.
· Galderma S.A.
· Biofarmitalia s.r.l
· Pharmatek Laboratories, Inc.
· Stiefel Laboratories, Inc.
· Tapemark
· Acrux Limited
· Nitto Denko Corporation
· Valeant Pharmaceuticals International, Inc.
· Skinvisible Pharmaceuticals, Inc.
· Mylan Pharmaceuticals Inc.
· Hisamitsu Pharmaceutical Co., Inc.
· Pocono Coated Products LLC
· TheraSolve NV.
· Samyang Biopharmaceuticals Corporation
· Lohmann Therapie-Systeme AG
· Prosollus Pharmaceuticals
· Easton Pharmaceuticals Inc.
· Novosis AG
· Antares Pharma, Inc.
· Endo Pharmaceuticals Inc.
· Transdermal Technologies, Inc.
· Sheffield Pharmaceuticals, Inc.
· Solvay
· 3M Drug Delivery Systems.
The
Europe Topical Drug Delivery Market is segmented on the basis of product type,
distribution channel, end user, and geography.
On
the basis of product type, the Europe Topical Drug Delivery Market is segmented
into transdermal drug delivery devices and topical drug delivery formulations.
Topical drug delivery formulations are further segmented based on form into
solid, semi-solid, and liquid. The semi solid segment is further classified
into ointments, creams, lotions, gels, and pastes. The solid drugs segment is
further segmented into powders and suppositors. The liquid drugs segment is
further classified into solutions and suspensions.
The
transdermal drug delivery devices market segment is further segmented into
patches and gels. In 2016, on the basis of product type topical drug delivery
formulations segment dominated the market by 72.6% share, however transdermal
drug delivery devices market is expected to grow at the highest CAGR of 14.1%
in the forecast period 2017 to 2024.
On
the basis of end users, the Europe Topical Drug Delivery Market is segmented
into hospitals, home healthcare, clinics, diagnostic centers, and others.
Based
on country, the Europe
Topical Drug Delivery Market is segmented into Germany, France, United
Kingdom., Belgium, Switzerland, Italy, Spain, Russia, Turkey, Netherlands and
Rest of Europe. The Europe topical drug delivery market is highly fragmented
with various companies operating in local regions. The major players have used
various strategies such as new product launches, expansions, agreements, joint
ventures, partnerships, acquisitions, and others to increase their footprints
in this market.
Inquiry
before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-topical-drug-delivery-market-trends-forecast24
Table
of Content:
1. INTRODUCTION
1.1. OVERVIEW OF
THE EUROPE TOPICAL DRUG DELIVERY MARKET
1.2. MARKET
SEGMENTATION & COVERAGE
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT
THE EUROPE TOPICAL DRUG DELIVERY MARKET SIZE
2.4. EUROPE
TOPICAL DRUG DELIVERY MARKET: RESEARCH SNAPSHOT
2.5. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. EUROPE TOPICAL
DRUG DELIVERY MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET
OVERVIEW
4.4. KEY MARKET
TRENDS AND UPCOMING TECHNOLOGIES
5. EXECUTIVE SUMMARY
6. TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. TOPICAL
DRUG DELIVERY, BY PRODUCT TYPE
6.2.1.
TRANSDERMAL DRUG DELIVERY DEVICES, BY PRODUCT TYPE
6.2.1.1. TRANSDERMAL PATCHES
6.2.1.2. TRANSDERMAL GELS
6.2.2. TOPICAL DRUG DELIVERY FORMULATIONS, BY FORM
6.2.2.1. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE
6.2.2.1.1. SOLUTIONS
6.2.2.1.2. SUSPENSIONS
6.2.2.2. SEMI-SOLID TOPICAL DRUG
DELIVERY FORMULATIONS, BY TYPE
6.2.2.2.1. GELS
6.2.2.2.2. CREAMS
6.2.2.2.3. OINTMENTS
6.2.2.2.4. PASTES
6.2.2.2.5.
LOTIONS
6.2.2.3. SOLID TOPICAL DRUG
DELIVERY FORMULATIONS, BY TYPE
6.2.2.3.1. SUPPOSITORIES
6.2.2.3.2. POWDERS
7. TOPICAL DRUG DELIVERY MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS
7.3. HOME
HEALTHCARE
7.4. CLINICS
7.5. DIAGNOSTIC
CENTERS
7.6. OTHERS
8. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. HOSPITAL
PHARMACIES
8.3. PHARMACY
STORES
8.4. DIRECT
TENDERS
8.5. ONLINE
PHARMACY
9. TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE
DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED
IN THIS CHAPTER BY COUNTRY)
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. TOPICAL DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE
10.1.
EUROPE TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.2. U.S.
TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.4. APAC
TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH
AMERICA TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.6.
MIDDLE EAST AND AFRICA TOPICAL DRUG
DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.7.
MERGERS & ACQUISITIONS
10.8. NEW
PRODUCT DEVELOPMENT & APPROVALS
10.10.
EXPANSIONS
10.10.
REGULATORY CHANGES
10.11.
PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. TOPICAL DRUG DELIVERY MARKET, COMPANY PROFILES
11.1. JANSSEN
PHARMACEUTICALS, INC. (A J&J COMPANY)
11.1.1. COMPANY OVERVIEW
11.1.2. SWOT ANALYSIS
11.1.3. REVENUE ANALYSIS
11.1.4. PRODUCT PORTFOLIO
11.1.5. RECENT DEVELOPEMENTS
11.1.5. DATA BRIDGE ANALYSIS
11.2. CRESCITA
THERAPEUTICS
11.2.1. COMPANY OVERVIEW
11.2.2. SWOT ANALYSIS
11.2.3. REVENUE ANALYSIS
11.2.4. PRODUCT PORTFOLIO
11.2.5. RECENT DEVELOPEMENTS
11.2.5. DATA BRIDGE ANALYSIS
11.3. GALDERMA
S.A.
11.3.1. COMPANY OVERVIEW
11.3.2. SWOT ANALYSIS
11.3.3. REVENUE ANALYSIS
11.3.4. PRODUCT PORTFOLIO
11.3.5. RECENT DEVELOPEMENTS
11.3.6. DATA BRIDGE ANALYSIS
11.4.
BIOFARMITALIA S.R.L
11.4.1. COMPANY OVERVIEW
11.4.2. SWOT ANALYSIS
11.4.3. REVENUE ANALYSIS
11.4.4. PRODUCT PORTFOLIO
11.4.5. RECENT DEVELOPEMENTS
11.4.5. DATA BRIDGE ANALYSIS
11.5.
PHARMATEK LABORATORIES, INC.
11.5.1. COMPANY OVERVIEW
11.5.2. SWOT ANALYSIS
11.5.3. REVENUE ANALYSIS
11.5.4. PRODUCT PORTFOLIO
11.5.5. RECENT DEVELOPEMENTS
11.5.5. DATA BRIDGE ANALYSIS
11.6. STIEFEL
LABORATORIES, INC.
11.6.1. COMPANY OVERVIEW
11.6.2. SWOT ANALYSIS
11.6.3. REVENUE ANALYSIS
11.6.4. PRODUCT PORTFOLIO
11.6.5. RECENT DEVELOPEMENTS
11.6.5. DATA BRIDGE ANALYSIS
11.7. TAPEMARK
11.7.1. COMPANY OVERVIEW
11.7.2. SWOT ANALYSIS
11.7.3. REVENUE ANALYSIS
11.7.4. PRODUCT PORTFOLIO
11.7.5. RECENT DEVELOPEMENTS
11.7.6. DATA BRIDGE ANALYSIS
11.8. NITTO
DENKO CORPORATION
11.8.1. COMPANY OVERVIEW
11.8.2. SWOT ANALYSIS
11.8.3. REVENUE ANALYSIS
11.8.4. PRODUCT PORTFOLIO
11.8.5. RECENT DEVELOPEMENTS
11.8.6. DATA BRIDGE ANALYSIS
11.9. VALEANT PHARMACEUTICALS INTERNATIONAL,
INC.
11.9.1. COMPANY OVERVIEW
11.9.2. SWOT ANALYSIS
11.9.3. REVENUE ANALYSIS
11.9.4. PRODUCT PORTFOLIO
11.9.5. RECENT DEVELOPEMENTS
11.9.6. DATA BRIDGE ANALYSIS
11.9. MYLAN
PHARMACEUTICALS INC.
11.9.1. COMPANY OVERVIEW
11.9.2. SWOT ANALYSIS
11.9.3. REVENUE ANALYSIS
11.9.4. PRODUCT PORTFOLIO
11.9.5. RECENT DEVELOPEMENTS
11.9.6. DATA BRIDGE ANALYSIS
11.9.
HISAMITSU PHARMACEUTICAL CO., INC.
11.9.1. COMPANY OVERVIEW
11.9.2. SWOT ANALYSIS
11.9.3. REVENUE ANALYSIS
11.9.4. PRODUCT PORTFOLIO
11.9.5. RECENT DEVELOPEMENTS
11.9.5. DATA BRIDGE ANALYSIS
11.10.
THERASOLVE NV.
11.10.1. COMPANY OVERVIEW
11.10.2. SWOT ANALYSIS
11.10.3. REVENUE ANALYSIS
11.10.4. PRODUCT PORTFOLIO
11.10.5. RECENT DEVELOPEMENTS
11.10.6. DATA BRIDGE ANALYSIS
11.11. SAMYANG
BIOPHARMACEUTICALS CORPORATION
11.11.1. COMPANY OVERVIEW
11.11.2. SWOT ANALYSIS
11.11.3. REVENUE ANALYSIS
11.11.4. PRODUCT PORTFOLIO
11.11.5. RECENT DEVELOPEMENTS
11.11.6. DATA BRIDGE ANALYSIS
11.12. LOHMANN
THERAPIE-SYSTEME AG
11.12.1. COMPANY OVERVIEW
11.12.2. SWOT ANALYSIS
11.12.3. REVENUE ANALYSIS
11.12.4.
PRODUCT PORTFOLIO
11.12.5.
RECENT DEVELOPEMENTS
11.12.6. DATA BRIDGE ANALYSIS
11.13.
PROSOLLUS PHARMACEUTICALS
11.13.1. COMPANY OVERVIEW
11.13.2. SWOT ANALYSIS
11.13.3. REVENUE ANALYSIS
11.13.4. PRODUCT PORTFOLIO
11.13.5. RECENT DEVELOPEMENTS
11.13.6. DATA BRIDGE ANALYSIS
11.14. EASTON
PHARMACEUTICALS INC.
11.14.1. COMPANY OVERVIEW
11.14.2. SWOT ANALYSIS
11.14.3. REVENUE ANALYSIS
11.14.4. PRODUCT PORTFOLIO
11.14.5. RECENT DEVELOPEMENTS
11.14.6. DATA BRIDGE ANALYSIS
11.15. ANTARES
PHARMA, INC.
11.15.1. COMPANY OVERVIEW
11.15.2. SWOT ANALYSIS
11.15.3. REVENUE ANALYSIS
11.15.4. PRODUCT PORTFOLIO
11.15.5. RECENT DEVELOPEMENTS
11.15.6. DATA BRIDGE ANALYSIS
11.16. ENDO
PHARMACEUTICALS INC.
11.16.1. COMPANY OVERVIEW
11.16.2. SWOT ANALYSIS
11.16.3. REVENUE ANALYSIS
11.16.4. PRODUCT PORTFOLIO
11.16.5. RECENT DEVELOPEMENTS
11.16.6. DATA BRIDGE ANALYSIS
11.17.
TRANSDERMAL TECHNOLOGIES, INC.
11.17.1. COMPANY OVERVIEW
11.17.2. SWOT ANALYSIS
11.17.3. REVENUE ANALYSIS
11.17.4. PRODUCT PORTFOLIO
11.17.5. RECENT DEVELOPEMENTS
11.17.6. DATA BRIDGE ANALYSIS
11.18.
SHEFFIELD PHARMACEUTICALS, INC.
11.18.1. COMPANY OVERVIEW
11.18.2. SWOT ANALYSIS
11.18.3. REVENUE ANALYSIS
11.18.4. PRODUCT PORTFOLIO
11.18.5. RECENT DEVELOPEMENTS
11.18.6. DATA BRIDGE ANALYSIS
11.19. SOLVAY
11.19.1. COMPANY OVERVIEW
11.19.2. SWOT ANALYSIS
11.19.3. REVENUE ANALYSIS
11.19.4. PRODUCT PORTFOLIO
11.19.5. RECENT DEVELOPEMENTS
11.19.6. DATA BRIDGE ANALYSIS
11.20. 3M DRUG
DELIVERY SYSTEMS
11.20.1. COMPANY OVERVIEW
11.20.2. SWOT ANALYSIS
11.20.3. REVENUE ANALYSIS
11.20.4. PRODUCT PORTFOLIO
11.20.5. RECENT DEVELOPEMENTS
11.20.6. DATA BRIDGE ANALYSIS
Browse Full Report Visit @ http://databridgemarketresearch.com/reports/europe-topical-drug-delivery-market-trends-forecast-2024/
Related
Report
Asia-Pacific
(APAC) Infusion Pumps Market – Industry Trends and Forecast to 2024
Asia-Pacific (APAC)
Infusion Pumps Market, By Product Types, By End-Users, By Distribution Channel,
By Country (Japan, China, South Korea, India, Australia, Singapore,
Thailand, Malaysia, Indonesia,
Phillipines, Rest of APAC) – Indutry Trends and Forecast to 2024
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Ankit
Singh
Data
Bridge Market Research
Tel:
+1-888-387-2818
Follow
us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research